These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 17149610

  • 1. CD34+ fibrocytes in chronic cystitis and noninvasive and invasive urothelial carcinomas of the urinary bladder.
    Nimphius W, Moll R, Olbert P, Ramaswamy A, Barth PJ.
    Virchows Arch; 2007 Feb; 450(2):179-85. PubMed ID: 17149610
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. CD34(+) fibrocytes in melanocytic nevi and malignant melanomas of the skin.
    Wessel C, Westhoff CC, Nowak K, Moll I, Barth PJ.
    Virchows Arch; 2008 Nov; 453(5):485-9. PubMed ID: 18813945
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions.
    Barth PJ, Ebrahimsade S, Ramaswamy A, Moll R.
    Virchows Arch; 2002 Mar; 440(3):298-303. PubMed ID: 11889601
    [Abstract] [Full Text] [Related]

  • 8. CD34(+) fibrocytes in normal cervical stroma, cervical intraepithelial neoplasia III, and invasive squamous cell carcinoma of the cervix uteri.
    Barth PJ, Ramaswamy A, Moll R.
    Virchows Arch; 2002 Dec; 441(6):564-8. PubMed ID: 12461613
    [Abstract] [Full Text] [Related]

  • 9. CD34+ fibrocytes in neoplastic and inflammatory pancreatic lesions.
    Barth PJ, Ebrahimsade S, Hellinger A, Moll R, Ramaswamy A.
    Virchows Arch; 2002 Feb; 440(2):128-133. PubMed ID: 11964041
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT).
    Miettinen M, Sobin LH, Sarlomo-Rikala M.
    Mod Pathol; 2000 Oct; 13(10):1134-42. PubMed ID: 11048809
    [Abstract] [Full Text] [Related]

  • 13. Variable stromal periductular expression of CD34 and smooth muscle actin (SMA) in intraductal carcinoma of the breast.
    Catteau X, Simon P, Vanhaeverbeek M, Noël JC.
    PLoS One; 2013 Oct; 8(3):e57773. PubMed ID: 23469238
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Diagnostic and prognostic impact of peritumoral stromal remodeling in patients with surgically treated invasive penile squamous cell cancer.
    Gunia S, Jain A, Albrecht K, Koch S, Otto W, Denzinger S, Götz S, Niessl N, Burger M, May M.
    Hum Pathol; 2014 Jun; 45(6):1169-76. PubMed ID: 24703102
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. CD34(low) and SMA(high) represent stromal signature in uterine cervical cancer and are markers for peritumoral stromal remodeling.
    Horn LC, Schreiter C, Canzler A, Leonhardt K, Einenkel J, Hentschel B.
    Ann Diagn Pathol; 2013 Dec; 17(6):531-5. PubMed ID: 24183311
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.